824413-96-9

Basic information

• Product Name: (4,4-DIFLUOROPIPERIDIN-YL)ACETONITRILE
• Synonyms: (4,4-DIFLUOROPIPERIDIN-YL)ACETONITRILE
• CAS NO: 824413-96-9
• Molecular Formula: C7H10F2N2
• Molecular Weight: 160.16
• Mol File: 824413-96-9.mol
• Article Data: 6

Chemical Properties

• Melting Point: 77-79°C
• Appearance: /
• CAS DataBase Reference: (4,4-DIFLUOROPIPERIDIN-YL)ACETONITRILE(CAS DataBase Reference)
• NIST Chemistry Reference: (4,4-DIFLUOROPIPERIDIN-YL)ACETONITRILE(824413-96-9)
• EPA Substance Registry System: (4,4-DIFLUOROPIPERIDIN-YL)ACETONITRILE(824413-96-9)

Safety Data

• Hazardous Substances Data: 824413-96-9(Hazardous Substances Data)

Usage

General Description

(4,4-DIFLUOROPIPERIDIN-YL)ACETONITRILE is a chemical compound with the molecular formula C7H8F2N2. It is a piperidine derivative with two fluorine atoms attached to the piperidine ring and a nitrile functional group attached to the piperidine nitrogen atom. (4,4-DIFLUOROPIPERIDIN-YL)ACETONITRILE is commonly used in the pharmaceutical and agrochemical industries as a building block in the synthesis of various pharmaceutical drugs and agrochemicals. It is also used as a reagent in organic synthesis for the preparation of diverse chemical compounds. The (4,4-DIFLUOROPIPERIDIN-YL)ACETONITRILE is an important intermediate in the production of a wide range of valuable compounds with potential applications in various fields.

Upstream product

• 144230-52-4 4,4-difluoropiperidine hydrochloride 
• 590-17-0 cyanomethyl bromide 
• 21987-29-1 4,4-difluoropiperidine 

Downstream Products

• 605659-03-8 2-(4,4-difluoropiperidin-1-yl)ethanamine 

Relevant articles and documents

INHIBITORS OF CELLULAR METABOLIC PROCESSES

The invention provides inhibitor compounds of MAT2A that are useful as therapeutic agents for treating malignancies wherein the compounds have the general formula (I) : wherein ring A, ring B, ring C and, R1 are as described herein.

TYK2 INHIBITORS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.

Aryl compounds with aminoalkyl substituents and their use

The present application relates to novel aryl compounds with aminoalkyl substituents, to processes for their preparation, to their use for treatment and/or prevention of diseases and to their use for the preparation of medicaments for treatment and/or prevention of diseases, in particular for treatment and/or prevention of hyperproliferative and angiogenic diseases and those diseases which arise from metabolic adaptation to hypoxic states. Such treatments can be carried out as monotherapy or also in combination with other medicaments or further therapeutic measures.